168 related articles for article (PubMed ID: 1409627)
1. Interleukin 6: a fibroblast-derived growth inhibitor of human melanoma cells from early but not advanced stages of tumor progression.
Lu C; Vickers MF; Kerbel RS
Proc Natl Acad Sci U S A; 1992 Oct; 89(19):9215-9. PubMed ID: 1409627
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-6 undergoes transition from paracrine growth inhibitor to autocrine stimulator during human melanoma progression.
Lu C; Kerbel RS
J Cell Biol; 1993 Mar; 120(5):1281-8. PubMed ID: 8436594
[TBL] [Abstract][Full Text] [Related]
3. Progressive loss of sensitivity to endothelium-derived growth inhibitors expressed by human melanoma cells during disease progression.
Rak JW; Hegmann EJ; Lu C; Kerbel RS
J Cell Physiol; 1994 May; 159(2):245-55. PubMed ID: 8163565
[TBL] [Abstract][Full Text] [Related]
4. Increased resistance to oncostatin M-induced growth inhibition of human melanoma cell lines derived from advanced-stage lesions.
Lu C; Rak JW; Kobayashi H; Kerbel RS
Cancer Res; 1993 Jun; 53(12):2708-11. PubMed ID: 8504408
[TBL] [Abstract][Full Text] [Related]
5. Fibroblast cell interactions with human melanoma cells affect tumor cell growth as a function of tumor progression.
Cornil I; Theodorescu D; Man S; Herlyn M; Jambrosic J; Kerbel RS
Proc Natl Acad Sci U S A; 1991 Jul; 88(14):6028-32. PubMed ID: 2068080
[TBL] [Abstract][Full Text] [Related]
6. Expression of leukemia inhibitory factor and interleukin-11 by human melanoma cell lines: LIF, IL-6, and IL-11 are not coregulated.
Paglia D; Oran A; Lu C; Kerbel RS; Sauder DN; McKenzie RC
J Interferon Cytokine Res; 1995 May; 15(5):455-60. PubMed ID: 7648448
[TBL] [Abstract][Full Text] [Related]
7. Antigenic profile of tumor progression stages in human melanocytic nevi and melanomas.
Elder DE; Rodeck U; Thurin J; Cardillo F; Clark WH; Stewart R; Herlyn M
Cancer Res; 1989 Sep; 49(18):5091-6. PubMed ID: 2548711
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-6 dependent induction of the cyclin dependent kinase inhibitor p21WAF1/CIP1 is lost during progression of human malignant melanoma.
Flørenes VA; Lu C; Bhattacharya N; Rak J; Sheehan C; Slingerland JM; Kerbel RS
Oncogene; 1999 Jan; 18(4):1023-32. PubMed ID: 10023678
[TBL] [Abstract][Full Text] [Related]
9. Analysis and significance of the malignant 'eclipse' during the progression of primary cutaneous human melanomas.
Kerbel RS; Kobayashi H; Graham CH; Lu C
J Investig Dermatol Symp Proc; 1996 Apr; 1(2):183-7. PubMed ID: 9627714
[TBL] [Abstract][Full Text] [Related]
10. Multiple features of advanced melanoma recapitulated in tumorigenic variants of early stage (radial growth phase) human melanoma cell lines: evidence for a dominant phenotype.
Bani MR; Rak J; Adachi D; Wiltshire R; Trent JM; Kerbel RS; Ben-David Y
Cancer Res; 1996 Jul; 56(13):3075-86. PubMed ID: 8674065
[TBL] [Abstract][Full Text] [Related]
11. Human growth factor for murine interleukin (IL)-9 responsive T cell lines: co-induction with IL-6 in fibroblasts and identification as LIF/HILDA.
Van Damme J; Uyttenhove C; Houssiau F; Put W; Proost P; Van Snick J
Eur J Immunol; 1992 Nov; 22(11):2801-8. PubMed ID: 1425908
[TBL] [Abstract][Full Text] [Related]
12. Endogenous interleukin 6 can function as an in vivo growth- stimulatory factor for advanced-stage human melanoma cells.
Lu C; Sheehan C; Rak JW; Chambers CA; Hozumi N; Kerbel RS
Clin Cancer Res; 1996 Aug; 2(8):1417-25. PubMed ID: 9816316
[TBL] [Abstract][Full Text] [Related]
13. Contribution of IL-6 to the antiproliferative effect of IL-1 and tumor necrosis factor on tumor cell lines.
Morinaga Y; Suzuki H; Takatsuki F; Akiyama Y; Taniyama T; Matsushima K; Onozaki K
J Immunol; 1989 Dec; 143(11):3538-42. PubMed ID: 2584706
[TBL] [Abstract][Full Text] [Related]
14. The 92-kDa gelatinase B is expressed by advanced stage melanoma cells: suppression by somatic cell hybridization with early stage melanoma cells.
MacDougall JR; Bani MR; Lin Y; Rak J; Kerbel RS
Cancer Res; 1995 Sep; 55(18):4174-81. PubMed ID: 7664294
[TBL] [Abstract][Full Text] [Related]
15. The melanoma differentiation-associated gene mda-6, which encodes the cyclin-dependent kinase inhibitor p21, is differentially expressed during growth, differentiation and progression in human melanoma cells.
Jiang H; Lin J; Su ZZ; Herlyn M; Kerbel RS; Weissman BE; Welch DR; Fisher PB
Oncogene; 1995 May; 10(9):1855-64. PubMed ID: 7753561
[TBL] [Abstract][Full Text] [Related]
16. Purification and characterization of tumor inhibitory factor-2: its identity to interleukin 1.
Fryling C; Dombalagian M; Burgess W; Hollander N; Schreiber AB; Haimovich J
Cancer Res; 1989 Jun; 49(12):3333-7. PubMed ID: 2785851
[TBL] [Abstract][Full Text] [Related]
17. Identification of a protein factor secreted by 3T3-L1 preadipocytes inhibitory for the human MCF-7 breast cancer cell line.
Johnston PG; Rondinone CM; Voeller D; Allegra CJ
Cancer Res; 1992 Dec; 52(24):6860-5. PubMed ID: 1458474
[TBL] [Abstract][Full Text] [Related]
18. Selection and characterization of a variant of human melanoma cell line, A375 resistant to growth inhibitory effects of oncostatin M (OM): coresistant to interleukin 6 (IL-6).
McDonald VL; Dick KO; Malik N; Shoyab M
Growth Factors; 1993; 9(3):167-75. PubMed ID: 8274294
[TBL] [Abstract][Full Text] [Related]
19. Osteonectin/SPARC induction by ectopic beta(3) integrin in human radial growth phase primary melanoma cells.
Sturm RA; Satyamoorthy K; Meier F; Gardiner BB; Smit DJ; Vaidya B; Herlyn M
Cancer Res; 2002 Jan; 62(1):226-32. PubMed ID: 11782382
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-4 (IL-4) in combination with IL-11 or IL-6 reverses the inhibitory effect of IL-3 on early B lymphocyte development.
Neben S; Donaldson D; Fitz L; Calvetti J; Neben T; Turner K; Hirayama F; Ogawa M
Exp Hematol; 1996 Jun; 24(7):783-9. PubMed ID: 8647228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
